Intranasal delivery has been used in clinical studies to deliver small-molecule agents to the brain, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), thus treating neurodegenerative diseases (73–75). Here, BDNF is linked to neurodegenerative disease.